177 related articles for article (PubMed ID: 34750269)
1. Rational prioritization strategy allows the design of macrolide derivatives that overcome antibiotic resistance.
König G; Sokkar P; Pryk N; Heinrich S; Möller D; Cimicata G; Matzov D; Dietze P; Thiel W; Bashan A; Bandow JE; Zuegg J; Yonath A; Schulz F; Sanchez-Garcia E
Proc Natl Acad Sci U S A; 2021 Nov; 118(46):. PubMed ID: 34750269
[TBL] [Abstract][Full Text] [Related]
2. Tryptamine derivatives disarm colistin resistance in polymyxin-resistant gram-negative bacteria.
Barker WT; Chandler CE; Melander RJ; Ernst RK; Melander C
Bioorg Med Chem; 2019 May; 27(9):1776-1788. PubMed ID: 30898435
[TBL] [Abstract][Full Text] [Related]
3. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Two Macrolide Resistance-Related Genes in Multidrug-Resistant
Chen Q; Lu W; Zhou D; Zheng G; Liu H; Qian C; Zhou W; Lu J; Ni L; Bao Q; Li A; Xu T; Xu H
Pol J Microbiol; 2020 Sep; 69(3):349-356. PubMed ID: 33574864
[TBL] [Abstract][Full Text] [Related]
5. The Anthelmintic Drug Niclosamide Synergizes with Colistin and Reverses Colistin Resistance in Gram-Negative Bacilli.
Domalaon R; De Silva PM; Kumar A; Zhanel GG; Schweizer F
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30917988
[TBL] [Abstract][Full Text] [Related]
6. Using experimental evolution to identify druggable targets that could inhibit the evolution of antimicrobial resistance.
Mehta HH; Prater AG; Shamoo Y
J Antibiot (Tokyo); 2018 Feb; 71(2):279-286. PubMed ID: 28928474
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effect of two antimicrobial peptides, Nisin and P10 with conventional antibiotics against extensively drug-resistant Acinetobacter baumannii and colistin-resistant Pseudomonas aeruginosa isolates.
Jahangiri A; Neshani A; Mirhosseini SA; Ghazvini K; Zare H; Sedighian H
Microb Pathog; 2021 Jan; 150():104700. PubMed ID: 33346078
[TBL] [Abstract][Full Text] [Related]
8. Discovery of Macrolide Antibiotics Effective against Multi-Drug Resistant Gram-Negative Pathogens.
Myers AG; Clark RB
Acc Chem Res; 2021 Apr; 54(7):1635-1645. PubMed ID: 33691070
[TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V
J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989
[TBL] [Abstract][Full Text] [Related]
10. Small Molecule Potentiation of Gram-Positive Selective Antibiotics against
Martin SE; Melander RJ; Brackett CM; Scott AJ; Chandler CE; Nguyen CM; Minrovic BM; Harrill SE; Ernst RK; Manoil C; Melander C
ACS Infect Dis; 2019 Jul; 5(7):1223-1230. PubMed ID: 31002491
[TBL] [Abstract][Full Text] [Related]
11. Performances of the Rapid Polymyxin
Lescat M; Poirel L; Jayol A; Nordmann P
Microb Drug Resist; 2019 May; 25(4):520-523. PubMed ID: 30508392
[No Abstract] [Full Text] [Related]
12. Antibiotic Cross-linked Micelles with Reduced Toxicity for Multidrug-Resistant Bacterial Sepsis Treatment.
Yang X; Ren H; Zhang H; Liu G; Jiang Z; Qiu Q; Yu C; Murthy N; Zhao K; Lovell JF; Zhang Y
ACS Appl Mater Interfaces; 2021 Mar; 13(8):9630-9642. PubMed ID: 33616382
[TBL] [Abstract][Full Text] [Related]
13. Vanillin selectively modulates the action of antibiotics against resistant bacteria.
Bezerra CF; Camilo CJ; do Nascimento Silva MK; de Freitas TS; Ribeiro-Filho J; Coutinho HDM
Microb Pathog; 2017 Dec; 113():265-268. PubMed ID: 29107747
[TBL] [Abstract][Full Text] [Related]
14. A broad-spectrum antibiotic adjuvant reverses multidrug-resistant Gram-negative pathogens.
Song M; Liu Y; Huang X; Ding S; Wang Y; Shen J; Zhu K
Nat Microbiol; 2020 Aug; 5(8):1040-1050. PubMed ID: 32424338
[TBL] [Abstract][Full Text] [Related]
15. In vitro synergistic activity of colistin and ceftazidime or ciprofloxacin against multidrug-resistant clinical strains of Pseudomonas aeruginosa.
D'Souza BB; Padmaraj SR; Rekha PD; Tellis RC; Prabhu S; Pothen P
Microb Drug Resist; 2014 Dec; 20(6):550-4. PubMed ID: 25055029
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis and In vitro Biological Activity of Some New 1,3- thiazolidine-4-one Derivatives as Chemotherapeutic Agents using Virtual Screening Strategies.
Nayak P; Kachroo M
Curr Comput Aided Drug Des; 2020; 16(6):757-771. PubMed ID: 31951175
[TBL] [Abstract][Full Text] [Related]
17. Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1-4.
Jenkins SG; Brown SD; Farrell DJ
Ann Clin Microbiol Antimicrob; 2008 Jan; 7():1. PubMed ID: 18190701
[TBL] [Abstract][Full Text] [Related]
18. [Activity of telithromycin and other oral antibiotics against respiratory tract pathogens with acquired mechanisms of resistance].
Gómez-Garcés JL; Alós JI; Hernáiz C; Gómez C
Enferm Infecc Microbiol Clin; 2004; 22(6):323-7. PubMed ID: 15228898
[TBL] [Abstract][Full Text] [Related]
19. Synergistic combinations of anthelmintic salicylanilides oxyclozanide, rafoxanide, and closantel with colistin eradicates multidrug-resistant colistin-resistant Gram-negative bacilli.
Domalaon R; Okunnu O; Zhanel GG; Schweizer F
J Antibiot (Tokyo); 2019 Aug; 72(8):605-616. PubMed ID: 31028351
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of solithromycin analogs against multidrug resistant pathogens.
Daher SS; Jin X; Patel J; Freundlich JS; Buttaro B; Andrade RB
Bioorg Med Chem Lett; 2019 Jun; 29(11):1386-1389. PubMed ID: 30962084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
